Express News | Innovative drug stocks fluctuated and declined, with Baili Tianheng and Dizhe Pharmaceuticals both falling more than 10%.

BreakingsJun 1 11:05

Express News | Midday Market Review: ChiNext Index Rebounds to Gain 0.21%; Power and Semiconductor Sectors Rally Collectively

BreakingsMay 28 11:31

HitGen Inc. (688222): Core business steadily recovering; bullish on long-term growth of DEL+ platform

Report Summary Event: The company released its 2025 annual report and Q1 2026 report. 1) In 2025, the company achieved revenue of RMB 526 million, an increase of 23.09% year-over-year; net profit attributable to shareholders was RMB 110 million, up

Zhongtai SecuritiesMay 26 14:37

Chengdu先导 (688222): Q1 2026 performance shows rapid growth; optimistic outlook for full-year results in a high-growth sector.

Event: In 2025, the company achieved revenue of 526 million yuan (yoy+23.09%), net profit attributable to shareholders of 110 million yuan (yoy+113.22%), and non-recurring net profit of 113 million yuan (yoy+96%).

Tianfeng SecuritiesMay 12 16:17

Chengdu先导 (688222): Core business segments achieve steady growth; new technology business segments realize commercialization.

Steady growth in performance for the full year 2025 and the first quarter of 2026. In 2025, the company achieved a total revenue of 526 million yuan (+23.09%) and a net profit attributable to shareholders of 110 million yuan (+113.22%). Excluding non-recurring items, the profit was...

Guosen SecuritiesMay 8 19:58

Express News | HitGen Inc.: Shareholders Huabo Medical Devices and Shenzhen Jun Tian plan to collectively reduce their holdings by no more than 3.51% of the company’s shares.

BreakingsMay 7 17:14